Presentations Corporate Presentation TCR2 Corporate Presentation - November 2020 3.4 MB TC-210 Phase 1 Interim Data TC-210 Phase 1 Interim Data 5.3 MB June 2020 - AACR Virtual Annual Meeting II A Chimeric PD1-CD28 Switch Receptor Enhances the Activity of TRuC-T Cells 2.7 MB Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuC™) T Cells 11.3 MB February 2020 - Keystone Symposia Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuCTM) T Cells 5.1 MB April 2019 - AACR Preclinical Evaluation of TC-110: CD19-Specific T Cell Receptor (TCR) Fusion Construct (TRuCTM) T Cells for the Treatment of Hematologic Malignancy 4.5 MB Preclinical Evaluation of TC-210: A Mesothelin-Specific T Cell Receptor (TCR) Fusion Construct (TRuCTM) T Cells for the Treatment of Solid Tumors 7.2 MB
June 2020 - AACR Virtual Annual Meeting II A Chimeric PD1-CD28 Switch Receptor Enhances the Activity of TRuC-T Cells 2.7 MB Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuC™) T Cells 11.3 MB
A Chimeric PD1-CD28 Switch Receptor Enhances the Activity of TRuC-T Cells 2.7 MB Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuC™) T Cells 11.3 MB
February 2020 - Keystone Symposia Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuCTM) T Cells 5.1 MB
April 2019 - AACR Preclinical Evaluation of TC-110: CD19-Specific T Cell Receptor (TCR) Fusion Construct (TRuCTM) T Cells for the Treatment of Hematologic Malignancy 4.5 MB Preclinical Evaluation of TC-210: A Mesothelin-Specific T Cell Receptor (TCR) Fusion Construct (TRuCTM) T Cells for the Treatment of Solid Tumors 7.2 MB
Preclinical Evaluation of TC-110: CD19-Specific T Cell Receptor (TCR) Fusion Construct (TRuCTM) T Cells for the Treatment of Hematologic Malignancy 4.5 MB Preclinical Evaluation of TC-210: A Mesothelin-Specific T Cell Receptor (TCR) Fusion Construct (TRuCTM) T Cells for the Treatment of Solid Tumors 7.2 MB
